Artículos por temáticas

Vitamin D receptor rs2228570 polymorphism and Parkinson's disease risk in a Chinese population

Hu W, Wang L, Chen B, Wang X.

Neurosci Lett. 2020 Jan 19;717:134722. doi: 10.1016/j.neulet.2019.134722. Epub 2019 Dec 23.

Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis

Fu P, Gao M, Yung KKL.

ACS Chem Neurosci. 2020 Feb 5;11(3):395-405. doi: 10.1021/acschemneuro.9b00607. Epub 2020 Jan 8.

Should respiratory muscle training be part of the treatment of Parkinson's disease? A systematic review of randomized controlled trials

Rodríguez MÁ, Crespo I, Del Valle M, Olmedillas H.

Clin Rehabil. 2020 Apr;34(4):429-437. doi: 10.1177/0269215519896054. Epub 2019 Dec 26.

Which Scale Best Detects Treatment Response of Tremor in Parkinsonism?

Pintér D, Forjaz MJ, Martinez-Martin P, Rodriguez-Blazquez C, Ayala A, Juhász A, Harmat M, Janszky J, Kovács N.

J Parkinsons Dis. 2020;10(1):275-282. doi: 10.3233/JPD-191800.

A Real-Life Search for the Optimal Set of Conversion Factors to Levodopa-Equivalent-Dose in Parkinson's Disease Patients on Polytherapy

Snineh MA, Hajyahya A, Linetsky E, Eitan R, Bergman H, Israel Z, Arkadir D.

J Parkinsons Dis. 2020;10(1):173-178. doi: 10.3233/JPD-191769.

Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease

Chen CH, Lee BC, Lin CH.

J Parkinsons Dis. 2020;10(1):77-88. doi: 10.3233/JPD-191766.

Ethnic Variation in the Manifestation of Parkinson's Disease: A Narrative Review

Ben-Joseph A, Marshall CR, Lees AJ, Noyce AJ.

J Parkinsons Dis. 2020;10(1):31-45. doi: 10.3233/JPD-191763.

Determinants of Low Body Mass Index in Patients with Parkinson's Disease: A Multicenter Case-Control Study

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Haruyama Y, Kobashi G, Sakakibara R, Shimo Y, Hatano T, Hattori N, Yamamoto T, Hirano S, Yamamoto T, Kuwabara S, Kaji Y, Fujita H, Kadowaki T, Hirata K.

J Parkinsons Dis. 2020;10(1):213-221. doi: 10.3233/JPD-191741.

Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson's Disease: The ICICLE-PD Study

Martin-Ruiz C, Williams-Gray CH, Yarnall AJ, Boucher JJ, Lawson RA, Wijeyekoon RS, Barker RA, Kolenda C, Parker C, Burn DJ, Von Zglinicki T, Saretzki G.

J Parkinsons Dis. 2020;10(1):193-206. doi: 10.3233/JPD-191724.

Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis

Schneider RB, Jimenez-Shahed J, Abraham DS, Thibault DP, Mantri S, Fullard M, Burack MA, Chou KL, Spindler M, Jermakowicz WJ, D'Haese PF, York MK, Kirk JC, Schwalb JM, Espay AJ, Shih LC, Simon DK, Hun

Parkinsonism Relat Disord. 2020 Jan;70:96-102. doi: 10.1016/j.parkreldis.2019.11.023. Epub 2019 Dec 19.

Decline in drawing ability and cerebral perfusion in Parkinson's disease patients after subthalamic nucleus deep brain stimulation surgery

Furukawa S, Hirano S, Yamamoto T, Asahina M, Uchiyama T, Yamanaka Y, Nakano Y, Ishikawa A, Kojima K, Abe M, Uji Y, Higuchi Y, Horikoshi T, Uno T, Kuwabara S.

Parkinsonism Relat Disord. 2020 Jan;70:60-66. doi: 10.1016/j.parkreldis.2019.12.002. Epub 2019 Dec 3.

Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.

de Germay S, Montastruc F, Carvajal A, Lapeyre-Mestre M, Montastruc JL.

Parkinsonism Relat Disord. 2020 Jan;70:55-59. doi: 10.1016/j.parkreldis.2019.12.011. Epub 2019 Dec 17.

Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study

Mahlknecht P, Stockner H, Marini K, Gasperi A, Djamshidian A, Willeit P, Kiechl S, Willeit J, Rungger G, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2020 Jan;70:51-54. doi: 10.1016/j.parkreldis.2019.12.008. Epub 2019 Dec 11.

Association between SNCA rs356220 polymorphism and Parkinson's disease: A meta-analysis

Bi M, Kang S, Du X, Jiao Q, Jiang H.

Neurosci Lett. 2020 Jan 19;717:134703. doi: 10.1016/j.neulet.2019.134703. Epub 2019 Dec 18.

Olfactory dysfunction correlates with putaminal dopamine turnover in early de novo Parkinson's disease

Löhle M, Wolz M, Beuthien-Baumann B, Oehme L, van den Hoff J, Kotzerke J, Reichmann H, Storch A.

J Neural Transm (Vienna). 2020 Jan;127(1):9-16. doi: 10.1007/s00702-019-02122-9. Epub 2019 Dec 20.